Login to Your Account

Oh, the Places You'll Go

So Far, Have Antibodies Just Scratched the Surface?

By Anette Breindl

Monday, October 3, 2011
Monoclonal antibodies are big business. According to a report published by Deloitte, global sales of just the top 10 monoclonal antibodies amounted to $3.6 billion in 2009. That report asserted that "monoclonal antibodies (mAbs) have become one of the most valuable and rapidly growing segments of the worldwide pharmaceutical industry."

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription